Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Biogen’s late-stage lupus candidates may not have crossed the FDA finish line yet, but the company has already hit the ground running with its patient advocacy work. | Biogen highlighted patient advocate and content creator Naomi Rose’s story living with cutaneous lupus erythematosus (CLE) on its social media platforms.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Explore how AI, advanced analytics and real-world data can help identify rare disease patients earlier, reduce diagnostic delays…

By Andreas Dimakakos Director of Clinical Data, Kate Smietana Director, Knowledge and Thought Leadership, Panos Karelis VP of…

Astellas CEO explained to Fierce the company's new five-year plan. A Takeda candidate beat Bristol Myers Squibb's Sotyktu in a…

With increased sales of its newer drugs compensating for declining revenues from its multiple sclerosis (MS) portfolio, Biogen is…

As AbbVie continues to capitalize on its deal for ImmunoGen with the growth of commercial antibody-drug conjugate (ADC) Elahere,…

The pharmaceutical industry is reaching a turning point in patient support. | Life sciences leaders say patient support is…